GB2260811B - Detection of malignant tumours - Google Patents

Detection of malignant tumours

Info

Publication number
GB2260811B
GB2260811B GB9122478A GB9122478A GB2260811B GB 2260811 B GB2260811 B GB 2260811B GB 9122478 A GB9122478 A GB 9122478A GB 9122478 A GB9122478 A GB 9122478A GB 2260811 B GB2260811 B GB 2260811B
Authority
GB
United Kingdom
Prior art keywords
detection
malignant tumours
tumours
malignant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
GB9122478A
Other versions
GB2260811A (en
GB9122478D0 (en
Inventor
Peter Selby
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
YORKSHIRE CANCER RESEARCH CAMP
University of Leeds
Original Assignee
YORKSHIRE CANCER RESEARCH CAMP
University of Leeds
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by YORKSHIRE CANCER RESEARCH CAMP, University of Leeds filed Critical YORKSHIRE CANCER RESEARCH CAMP
Priority to GB9122478A priority Critical patent/GB2260811B/en
Publication of GB9122478D0 publication Critical patent/GB9122478D0/en
Publication of GB2260811A publication Critical patent/GB2260811A/en
Application granted granted Critical
Publication of GB2260811B publication Critical patent/GB2260811B/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/686—Polymerase chain reaction [PCR]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
GB9122478A 1991-10-23 1991-10-23 Detection of malignant tumours Expired - Lifetime GB2260811B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB9122478A GB2260811B (en) 1991-10-23 1991-10-23 Detection of malignant tumours

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9122478A GB2260811B (en) 1991-10-23 1991-10-23 Detection of malignant tumours

Publications (3)

Publication Number Publication Date
GB9122478D0 GB9122478D0 (en) 1991-12-04
GB2260811A GB2260811A (en) 1993-04-28
GB2260811B true GB2260811B (en) 1995-07-05

Family

ID=10703394

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9122478A Expired - Lifetime GB2260811B (en) 1991-10-23 1991-10-23 Detection of malignant tumours

Country Status (1)

Country Link
GB (1) GB2260811B (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6428955B1 (en) 1995-03-17 2002-08-06 Sequenom, Inc. DNA diagnostics based on mass spectrometry
US6468748B1 (en) 1996-03-04 2002-10-22 Sequenom, Inc. Methods of screening nucleic acids using volatile salts in mass spectrometry
US6500621B2 (en) 1995-03-17 2002-12-31 Sequenom, Inc. DNA diagnostics based on mass spectrometry
US6566055B1 (en) 1996-09-19 2003-05-20 Sequenom, Inc. Methods of preparing nucleic acids for mass spectrometric analysis
US6635452B1 (en) 1996-12-10 2003-10-21 Sequenom Inc. Releasable nonvolatile mass label molecules
US6660229B2 (en) 2000-06-13 2003-12-09 The Trustees Of Boston University Use of nucleotide analogs in the analysis of oligonucleotide mixtures and in highly multiplexed nucleic acid sequencing

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6153388A (en) * 1994-10-27 2000-11-28 University Of South Florida Method of determining melanoma micrometastasis using tyrosinase
DE19681033D2 (en) 1995-11-16 1999-03-18 Michael W Dahm Method for the quantification of tumor cells in a body fluid and suitable test kits
GB9613629D0 (en) * 1996-06-28 1996-08-28 Univ Leeds Reg gene expression in cancer tissue
JPH1057064A (en) 1996-08-16 1998-03-03 Rikagaku Kenkyusho Specific amplification of minor gene product
US20030129589A1 (en) * 1996-11-06 2003-07-10 Hubert Koster Dna diagnostics based on mass spectrometry
NO972006D0 (en) 1997-04-30 1997-04-30 Forskningsparken I Aas As New method for diagnosis of diseases
DE19804372A1 (en) 1998-02-04 1999-08-05 Michael W Dr Dr Dahm Method for the quantitative determination of tumor cells in a body fluid and suitable test kits
GB0412301D0 (en) 2004-06-02 2004-07-07 Diagenic As Product and method

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990009456A1 (en) * 1989-02-16 1990-08-23 Viktor Balazs Malignancy test (cancer test) using the polymerase chain reaction
WO1991005064A1 (en) * 1989-10-02 1991-04-18 The United States Of America, As Represented By The Secretary, U.S. Department Of Commerce A sensitive method for measurement of chimeric transcripts of dna containing translocations
US5057410A (en) * 1988-08-05 1991-10-15 Cetus Corporation Chimeric messenger RNA detection methods

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5057410A (en) * 1988-08-05 1991-10-15 Cetus Corporation Chimeric messenger RNA detection methods
WO1990009456A1 (en) * 1989-02-16 1990-08-23 Viktor Balazs Malignancy test (cancer test) using the polymerase chain reaction
WO1991005064A1 (en) * 1989-10-02 1991-04-18 The United States Of America, As Represented By The Secretary, U.S. Department Of Commerce A sensitive method for measurement of chimeric transcripts of dna containing translocations

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Blood 1988, 72(6), 2063-2068 *

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6428955B1 (en) 1995-03-17 2002-08-06 Sequenom, Inc. DNA diagnostics based on mass spectrometry
US6500621B2 (en) 1995-03-17 2002-12-31 Sequenom, Inc. DNA diagnostics based on mass spectrometry
US6589485B2 (en) 1995-03-17 2003-07-08 Sequenom, Inc. Solid support for mass spectrometry
US6602662B1 (en) 1995-03-17 2003-08-05 Sequenom, Inc. DNA diagnostics based on mass spectrometry
US7759065B2 (en) 1995-03-17 2010-07-20 Sequenom, Inc. Mass spectrometric methods for detecting mutations in a target nucleic acid
US6468748B1 (en) 1996-03-04 2002-10-22 Sequenom, Inc. Methods of screening nucleic acids using volatile salts in mass spectrometry
US6566055B1 (en) 1996-09-19 2003-05-20 Sequenom, Inc. Methods of preparing nucleic acids for mass spectrometric analysis
US6635452B1 (en) 1996-12-10 2003-10-21 Sequenom Inc. Releasable nonvolatile mass label molecules
US8486623B2 (en) 1996-12-10 2013-07-16 Sequenom, Inc. Releasable nonvolatile mass-label molecules
US6660229B2 (en) 2000-06-13 2003-12-09 The Trustees Of Boston University Use of nucleotide analogs in the analysis of oligonucleotide mixtures and in highly multiplexed nucleic acid sequencing

Also Published As

Publication number Publication date
GB2260811A (en) 1993-04-28
GB9122478D0 (en) 1991-12-04

Similar Documents

Publication Publication Date Title
IL91193A0 (en) Detection of malignancies
GB2245970B (en) Particle detection
HU9302636D0 (en) Compounds against cancer
EP0519409A3 (en) Luster detector
GB2260811B (en) Detection of malignant tumours
GB8809359D0 (en) Inductive proximity detector
GB9008870D0 (en) Proximity detector
EP0474187A3 (en) Particle measuring aparatus
GB9003893D0 (en) Detector of metalliferous objects
ZA9291B (en) Process for the detection and localization of cancer
GB9224898D0 (en) Detection
EP0572563A4 (en) Treatment of esophageal cancer
EP0528689A3 (en) Detector
AU2479292A (en) Methods and compositions for the detection and prediction of breast cancer
GB9120633D0 (en) Detection of malignant and pre-malignant conditions
GB9003892D0 (en) Metalliferous objects detector
IL99630A0 (en) Novel antibodies useful for the detection of benign and malignant tumors
GB9009294D0 (en) Detection of malignancy
IL108269A0 (en) A method of using novel antibodies for the detection of benign and malignant tumours
GB2256762B (en) Direct detection of FSK
ZA912176B (en) Proximity detector
PL286501A1 (en) Magnetic proximity detector
CA68043S (en) Face shield
PL289779A1 (en) Segmented proximity detector
GB9103752D0 (en) Detection of species

Legal Events

Date Code Title Description
PE20 Patent expired after termination of 20 years

Expiry date: 20111022